CN Patent
CN109563096A — 固体形式的维奈托克和用于制备维奈托克的方法
Assigned to Dr Reddys Laboratories Ltd · Expires 2019-04-02 · 7y expired
What this patent protects
本申请的方面涉及固体形式的维奈托克及其制备方法。特定方面涉及无定形形式的维奈托克、其固体分散体以及维奈托克或其盐的结晶形式。本申请的其他方面涉及用于制备维奈托克的方法。
USPTO Abstract
本申请的方面涉及固体形式的维奈托克及其制备方法。特定方面涉及无定形形式的维奈托克、其固体分散体以及维奈托克或其盐的结晶形式。本申请的其他方面涉及用于制备维奈托克的方法。
Drugs covered by this patent
- Venclexta (venetoclax) · AbbVie
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.